Frühe effekte nach systemischer und intravitrealer bevacizumab (Avastin®)-therapie bei neovaskulärer altersbedingter makuladegeneration

Translated title of the contribution: Early effects of systemic and intravitreal bevacizumab (Avastin®) therapy for neovascular age-related macular degeneration

W. Geitzenauer, Stephan Michels, F. Prager, G. Kornek, L. Vormittag, P. Rosenfeld, U. Schmidt-Erfurth

Research output: Contribution to journalArticlepeer-review

23 Scopus citations

Fingerprint

Dive into the research topics of 'Early effects of systemic and intravitreal bevacizumab (Avastin®) therapy for neovascular age-related macular degeneration'. Together they form a unique fingerprint.

Medicine & Life Sciences